U Penn Cancer Center Initiative Builds Bridge Between Clinical and Genomic Data | GenomeWeb

Few would deny the potential benefits of marrying clinical and genomic data — linking knowledge of molecular-level mechanisms with the physiological effects of human disease may be the only way to relieve the target validation bottleneck now facing the industry. However, bringing these two ends of the pipeline together offers a number of technical, logistical, and cultural challenges that have proven difficult to overcome.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.